Net profit of Alembic Pharmaceuticals declined 3.94% to Rs 132.97 crore in the quarter ended December 2025 as against Rs 138.42 crore during the previous quarter ended December 2024. Sales rose 10.84% to Rs 1876.31 crore in the quarter ended December 2025 as against Rs 1692.74 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended |
| Dec. 2025 | Dec. 2024 | % Var. |
| Sales | 1876.31 | 1692.74 | 11 |
| OPM % | 15.54 | 15.37 | - |
| PBDT | 283.85 | 247.82 | 15 |
| PBT | 203.73 | 177.78 | 15 |
| NP | 132.97 | 138.42 | -4 |